Latest News about BMY
Recent news which mentions BMY
FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain Type Of Gene Mutation
June 24, 2024
From Benzinga
7 Dividend Stocks to Buy Now: June 2024
June 23, 2024
From InvestorPlace
3 No-Brainer Stocks to Buy for Under $100 Right Now
June 22, 2024
From Motley Fool
From Motley Fool
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
From Benzinga
From Benzinga
3 Warren Buffett Stocks to Buy Now: June 2024
June 19, 2024
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
June 19, 2024
From Benzinga
From Motley Fool
From InvestorPlace
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
June 15, 2024
From Motley Fool
From InvestorPlace
From InvestorPlace
From InvestorPlace
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
June 07, 2024
From Benzinga
From Benzinga
Bristol Myers Squibb Announces Phase 3 Results Of Opdivo/Yervoy Combo In Liver Cancer Patients
June 04, 2024
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
Tags
JD
NASDAQ:ADBE,NASDAQ:BIDU,NASDAQ:JD,NYSE:BMY,NASDAQ:EXAI,NASDAQ:ADSK,NYSE:GPN,NYSE:MED,NYSE:CPAY
CPAY
From InvestorPlace
Are Boomers Crashing The Economy Or Saving It? Why Investors Are Perplexed And What You Can Do To Prepare
May 29, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free